The Department of cell physiology and metabolism is always looking for motivated master students, PhD students and postdoctoral fellows.
Please contact the researcher indicated on the offer or the researcher in charge of any group you are interested in.
Supplementary information about masters at the University of Geneva: here
NO SPECIFIC MASTER OFFERS AT THE MOMENT
LIFE SCIENCES PHD SCHOOL
The primary track is to postulate to the doctoral school in life sciences.
Alternatively, you can apply to one of the offers below, but your application would have to be validated by the doctoral school (please refer to their conditions).
The laboratory directed by Prof. Roberto Coppari has been supported by several internationally and nationally competitive grants (e.g. European Research Council, Juvenile Diabetes Research Foundation, Swiss National Science Foundation grants). Thus, the laboratory is well-equipped and well-funded. It is currently looking for very motivated applicants interested in working on diabetes and/or cancer research. The team is particularly interested in considering applications from people wishing to pursue a career in science.
Several open positions at the level of PhD student and Post-Doctoral fellow are currently available. Please note that with the goal of identifying new molecular targets for better anti-diabetes therapy the laboratory aims at unraveling mechanisms permitting life without insulin. With the goal of identifying new molecular targets for better anti-cancer therapy, it exploits the outcomes of metabolic challenges to unravel cancer vulnerabilities.
If you are interested in embarking on challenging and rewarding projects in the aforementioned topics, please contact Prof. Roberto Coppari at the following email address:
In the subject of your email please write: application_diabetes_cancer. Please, also provide a copy of your curriculum vitae and 2 or 3 letters of reference.
See in the PhD students section the offer from Coppari laboratory "identifying new molecular targets for better anti-diabetes therapy"